Cargando…
The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research
Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer with an imperative need for new treatments. Immunotherapy has had marked success in some cancer types; however, clinical trials studying the efficacy of immune checkpoint inhibitors for the treatment of EOC benefited less than 15%...
Autores principales: | Rodriguez, Galaxia M., Galpin, Kristianne J.C., Cook, David P., Yakubovich, Edward, Maranda, Vincent, Macdonald, Elizabeth A., Wilson-Sanchez, Juliette, Thomas, Anjali L., Burdette, Joanna E., Vanderhyden, Barbara C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616009/ https://www.ncbi.nlm.nih.gov/pubmed/36311166 http://dx.doi.org/10.1158/2767-9764.CRC-22-0017 |
Ejemplares similares
-
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018) -
The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
por: Rodriguez, Galaxia M., et al.
Publicado: (2018) -
BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
por: Farokhi Boroujeni, Salar, et al.
Publicado: (2023) -
LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model
por: Mehdi, Sadia, et al.
Publicado: (2020) -
Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
por: Cook, David P., et al.
Publicado: (2023)